Survival comparison between 2 groups with single ACAs based on ACA emerging phase. (A-B) Survival comparison in patients with ACAs emerging from CP. (C-D) Survival comparison in patients with ACAs emerging from AP and BP. For panels A and C, OS was calculated from the time of ACA emergence. For panels B and D, OS was calculated from the time of CML diagnosis.